1-3 of 3
Jin Jie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Experience with Selinexor -Containing Regimens in Post-Transplant AML/MDS Patients Who MRD Still Positive after First-Line Preemptive Treatment

Xiwen Tong, Shuai Su, Bin Xu, Xiaojian Zhu, Yizhou Peng, Jin Jie, Xia Mao, Min Xiao, Jay Mei, Donghua Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5837.
https://doi.org/10.1182/blood-2023-186006
Published: 2023
Journal Articles

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Jin Jie, MD PhD, Siguo Hao, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Min Yang, MD PhD, Wenhao Zhang, MD PhD, Kang Yu, MD, Jun Xiao, MD, Haitao Meng, MD PhD, Liyuan Ma, MD PhD, Mingxia He, MD, Wei WANG, MD PhD, Xin Huang, MD PhD, Linjun Chen, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Shasha Wang, MD PhD, Rong Tao, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4435.
https://doi.org/10.1182/blood-2019-126104
Published: 2019
Journal Articles

Efficacy and Safety of Eltrombopag in Chinese Patients with Chronic Immune Thrombocytopenia: Stage 2 Results from a Multicenter Phase III Study

Renchi Yang, MD, Liu Xiaofan, MD, Junmin Li, MD, Ming Hou, MD PhD, Jin Jie, MD, Meijuan Huang, MD, Ziqiang Yu, PhD, Xiaojun Xu, MD PhD, Xiaohui Zhang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3760.
https://doi.org/10.1182/blood-2018-99-110501
Published: 2018